journal article·2023-06-28Open access

Novel Gadolinium-Free Ultrasmall Nanostructured Positive Contrast for Magnetic Resonance Angiography and Imaging

Rodrigo Ken Kawassaki, Mariana Romano, Mayara Klimuk Uchiyama, Roberta Mansini Cardoso, Maurício S. Baptista, Sandra H. P. Farsky, Khallil Taverna Chaim, Robson Raphael Guimarães, Koiti Araki

Nano Letters· Volume 23· Issue 12

Abstract

High Resolution Image Download MS PowerPoint Slide Nanostructured contrast agents are promising alternatives to Gd 3+ -based chelates in magnetic resonance (MR) imaging techniques. A novel ultrasmall paramagnetic nanoparticle (UPN) was strategically designed to maximize the number of exposed paramagnetic sites and r 1 while minimizing r 2, by decorating 3 nm titanium dioxide nanoparticles with suitable amounts of iron oxide. Its relaxometric parameters are comparable to those of gadoteric acid (GA) in agar phantoms, and the r 2 / r 1 ratio of 1.38 at 3 T is close to the ideal unitary value. The strong and prolonged contrast enhancement of UPN before renal excretion was confirmed by T 1 -weighted MR images of Wistar rats after intravenous bolus injection. Those results associated with good biocompatibility indicate its high potential as an alternative blood-pool contrast agent to the GA gold standard for MR angiography, especially for patients with severe renal impairment.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Characterization and Applications of Magnetic Nanoparticles

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Laboratory of Supramolecular Chemistry and Nanotechnology, Department of Fundamental Chemistry, Institute of Chemistry, University of Sao Paulo, Sao Paulo 05508-000, Brazil

Laboratory of Magnetic Resonance in Neuroradiology (LIM44), Department of Radiology and Oncology, Faculty of Medicine, University of Sao Paulo, Sao Paulo 01246-903, Brazil

Laboratory of Interfaces and Photoinduced Processes, Department of Biochemistry, Institute of Chemistry, University of Sao Paulo, Sao Paulo 05508-000, Brazil

Laboratory of Inflammation and Immunotoxicology, Department of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo 05508-000, Brazil

Imaging Platform (PISA), Hospital das Clinicas HCFMUSP, Faculty of Medicine, University of Sao Paulo, Sao Paulo 01246-903, Brazil

Funding

Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico · Funda??o de Amparo ? Pesquisa do Estado de S?o Paulo · Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior

References (56)

Show source-provided references
1. 10.1002/adma.20190653910.1002/adma.201906539 ↗
2. 10.1016/j.mattod.2015.11.00610.1016/j.mattod.2015.11.006 ↗
3. 10.3174/ajnr.A461510.3174/ajnr.A4615 ↗
4. 10.1007/s10534-016-9931-710.1007/s10534-016-9931-7 ↗
5. 10.1111/bcp.1371810.1111/bcp.13718 ↗
6. 10.1148/radiol.201716159510.1148/radiol.2017161595 ↗
7. 10.3390/ma1311258610.3390/ma13112586 ↗
8. 10.1021/acsanm.2c0329710.1021/acsanm.2c03297 ↗
9. 10.1016/j.coph.2014.08.00210.1016/j.coph.2014.08.002 ↗
10. 10.1038/s41598-018-19628-z10.1038/s41598-018-19628-z ↗
11. 10.1039/C9NR05624F10.1039/C9NR05624F ↗
12. 10.1038/s41598-019-43650-410.1038/s41598-019-43650-4 ↗
13. 10.1021/nl902715v10.1021/nl902715v ↗
14. 10.1021/JA203340U10.1021/JA203340U ↗
15. 10.1021/acsnano.7b0492410.1021/acsnano.7b04924 ↗
16. 10.1073/pnas.162014511410.1073/pnas.1620145114 ↗
17. 10.1039/C7TB01588G10.1039/C7TB01588G ↗
18. 10.1039/C7TC05854C10.1039/C7TC05854C ↗
19. 10.1021/acs.nanolett.8b0441110.1021/acs.nanolett.8b04411 ↗
20. 10.1016/j.jcis.2020.08.02610.1016/j.jcis.2020.08.026 ↗
21. 10.1039/D0NR06378A10.1039/D0NR06378A ↗
22. 10.1186/s12968-017-0422-y10.1186/s12968-017-0422-y ↗
23. 10.1148/RADIOL.201919047710.1148/RADIOL.2019190477 ↗
24. 10.1002/jmri.2845710.1002/jmri.28457 ↗
25. 10.1097/01.rli.0000133944.30119.cc10.1097/01.rli.0000133944.30119.cc ↗
26. 10.1002/jmri.2268310.1002/jmri.22683 ↗
27. 10.1097/RLI.000000000000032110.1097/RLI.0000000000000321 ↗
28. 10.1021/acsabm.8b0001610.1021/acsabm.8b00016 ↗
29. 10.1016/j.petrol.2022.11031110.1016/j.petrol.2022.110311 ↗
30. 10.1039/C4CS00487F10.1039/C4CS00487F ↗
31. 10.3109/17435390.2010.53661510.3109/17435390.2010.536615 ↗
32. 10.1021/nn200749610.1021/nn2007496 ↗
33. 10.1016/j.toxlet.2011.11.00610.1016/j.toxlet.2011.11.006 ↗
34. 10.1021/acs.chemrestox.6b0010810.1021/acs.chemrestox.6b00108 ↗
35. 10.1088/2053-1591/AA96E310.1088/2053-1591/AA96E3 ↗
36. 10.1021/acsnano.7b0003810.1021/acsnano.7b00038 ↗
37. 10.1038/nmat471810.1038/nmat4718 ↗
38. 10.1021/acsnano.9b0138310.1021/acsnano.9b01383 ↗
39. International Organization for Standardization. ISO 10993-5:2009 - Biological Evaluation of Medical Devices - Part 5: Tests for in Vitro Cytotoxicity. 2009. https://www.iso.org/standard/36406.html (accessed 2022-01-27).
40. 10.1039/C5NR03701H10.1039/C5NR03701H ↗
41. 10.1002/smll.20190155110.1002/smll.201901551 ↗
42. 10.1038/nnano.2017.6110.1038/nnano.2017.61 ↗
43. 10.1016/j.colsurfb.2018.06.05110.1016/j.colsurfb.2018.06.051 ↗
44. 10.1038/nnano.2015.33010.1038/nnano.2015.330 ↗
45. 10.1002/jbm.a.3643810.1002/jbm.a.36438 ↗
46. 10.1166/jnn.2021.1902710.1166/jnn.2021.19027 ↗
47. 10.1007/s00216-017-0622-110.1007/s00216-017-0622-1 ↗
48. 10.1097/01.rli.0000184756.66360.d310.1097/01.rli.0000184756.66360.d3 ↗
49. 10.1097/RLI.000000000000043410.1097/RLI.0000000000000434 ↗
50. 10.1007/s00330-005-0031-210.1007/s00330-005-0031-2 ↗
51. 10.2147/RMI.S4679810.2147/RMI.S46798 ↗
52. 10.1038/s41578-018-0038-310.1038/s41578-018-0038-3 ↗
53. 10.3390/ijms22201118210.3390/ijms222011182 ↗
54. 10.1088/1361-6528/aabbd010.1088/1361-6528/aabbd0 ↗
55. 10.1021/acsnano.9b0151110.1021/acsnano.9b01511 ↗
56. 10.1111/j.1600-0560.2009.01283.x10.1111/j.1600-0560.2009.01283.x ↗